Search research articles
Contact Us
Filters
Showing results (11-20 of 92) with videos related to
Page
of 10
Sort By:
Nucleic Acids Research
|
March 24, 2017
In vivo cleavage specificity of Trypanosoma brucei editosome endonucleases
Jason Carnes, Suzanne McDermott, Atashi Anupama, et al.
Frontiers in Cellular and Infection Microbiology
|
April 23, 2024
Deep mutational scanning of the RNase III-like domain in <i>Trypanosoma brucei</i> RNA editing protein KREPB4
Suzanne M McDermott, Vy Pham, Brian Oliver, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2016
Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses
Katherine J Nicholas, David K Flaherty, Rita M Smith, et al.
NPJ Vaccines
|
December 6, 2024
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy
Naveen Yadav, Anya C Kalata, Rebekah A Reynolds, et al.
Research Square
|
October 14, 2024
Identifying <i>Plasmodium</i> P36 and P52 antigens for co-administration with circumsporozoite protein to enhance vaccine efficacy
Naveen Yadav, Anya C Kalata, Rebekah A Reynolds, et al.
Plant Methods
|
July 4, 2009
Development of a gene silencing DNA vector derived from a broad host range geminivirus
Edward M Golenberg, D Noah Sather, Leandria C Hancock, et al.
Journal of Virology
|
September 14, 2012
Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus
D Noah Sather, Sara Carbonetti, Jenny Kehayia, et al.
Plos One
|
May 30, 2020
Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates
Bridget S Fisher, Nicholas Dambrauskas, Olesya Trakhimets, et al.
Frontiers in Pharmacology
|
July 1, 2021
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 92) with videos related to
Sort By:
Page
of 10
Nucleic Acids Research
|
March 24, 2017
In vivo cleavage specificity of Trypanosoma brucei editosome endonucleases
Jason Carnes, Suzanne McDermott, Atashi Anupama, et al.
Frontiers in Cellular and Infection Microbiology
|
April 23, 2024
Deep mutational scanning of the RNase III-like domain in <i>Trypanosoma brucei</i> RNA editing protein KREPB4
Suzanne M McDermott, Vy Pham, Brian Oliver, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2016
Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses
Katherine J Nicholas, David K Flaherty, Rita M Smith, et al.
NPJ Vaccines
|
December 6, 2024
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy
Naveen Yadav, Anya C Kalata, Rebekah A Reynolds, et al.
Research Square
|
October 14, 2024
Identifying <i>Plasmodium</i> P36 and P52 antigens for co-administration with circumsporozoite protein to enhance vaccine efficacy
Naveen Yadav, Anya C Kalata, Rebekah A Reynolds, et al.
Plant Methods
|
July 4, 2009
Development of a gene silencing DNA vector derived from a broad host range geminivirus
Edward M Golenberg, D Noah Sather, Leandria C Hancock, et al.
Journal of Virology
|
September 14, 2012
Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus
D Noah Sather, Sara Carbonetti, Jenny Kehayia, et al.
Plos One
|
May 30, 2020
Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates
Bridget S Fisher, Nicholas Dambrauskas, Olesya Trakhimets, et al.
Frontiers in Pharmacology
|
July 1, 2021
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2
Kaleb B Tsegay, Christiana M Adeyemi, Edward P Gniffke, et al.
Page
of 10